PRMT5 Inhibition Enhances Elimination of FLT3-ITD AML Stem Cells in Combination with TKI Treatment

被引：1
|
作者：
Kumar, Harish [1 ]
Dhir, Aditi [2 ]
Paterson, Andrew J. [3 ]
Anderson, Nick R. [4 ]
Qiu, Shaowei [4 ]
Zhao, Xinyang [5 ]
Lu, Rui [4 ]
Bhatia, Ravi [4 ]
机构：
[1] Univ Alabama Birmingham, Dept Med, UAB, Div Hematol & Oncol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Div Hematol & Oncol, Dept Med, Birmingham, AL 35294 USA
[5] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-168326
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3073 / 3074
页数：2
相关论文
共 50 条
  • [21] Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells
    Larrue, Clement
    Saland, Estelle
    Boutzen, Helena
    Vergez, Francois
    David, Marion
    Joffre, Carine
    Hospital, Marie-Anne
    Tamburini, Jerome
    Delabesse, Eric
    Manenti, Stephane
    Sarry, Jean Emmanuel
    Recher, Christian
    BLOOD, 2016, 127 (07) : 882 - 892
  • [22] RIPK1 inhibition enhances the therapeutic efficacy of chidamide in FLT3-ITD positive AML, both in vitro and in vivo
    Li, Jun
    Liao, Dan
    Wang, Fujue
    Wang, Zhongwang
    Li, Yueshan
    Xiong, Yu
    Niu, Ting
    LEUKEMIA & LYMPHOMA, 2022, 63 (05) : 1167 - 1179
  • [23] Autophagy inhibition impairs leukemia stem cell function in FLT3-ITD AML but has antagonistic interactions with tyrosine kinase inhibition
    Shaowei Qiu
    Harish Kumar
    Chengcheng Yan
    Hui Li
    Andrew J. Paterson
    Nicholas R. Anderson
    Jianbo He
    Jing Yang
    Min Xie
    David K. Crossman
    Rui Lu
    Robert S. Welner
    Ravi Bhatia
    Leukemia, 2022, 36 : 2621 - 2633
  • [24] Autophagy inhibition impairs leukemia stem cell function in FLT3-ITD AML but has antagonistic interactions with tyrosine kinase inhibition
    Qiu, Shaowei
    Kumar, Harish
    Yan, Chengcheng
    Li, Hui
    Paterson, Andrew J.
    Anderson, Nicholas R.
    He, Jianbo
    Yang, Jing
    Xie, Min
    Crossman, David K.
    Lu, Rui
    Welner, Robert S.
    Bhatia, Ravi
    LEUKEMIA, 2022, 36 (11) : 2621 - 2633
  • [25] Proteasome Inhibitors Induce FLT3-ITD Degradation through Autophagy in AML Cells
    Larrue, C.
    Saland, E.
    Boutzen, H.
    David, M.
    Joffre, C.
    Delabesse, E.
    Manenti, S.
    Sarry, J. E.
    Recher, C.
    ANNALS OF HEMATOLOGY, 2015, 94 : S79 - S80
  • [26] A Novel Combination Regimen of BET and FLT3 Inhibition for FLT3-ITD Acute Myeloid Leukemia
    Lee, Lauren
    Hizukuri, Yoshiyuki
    Severson, Paul
    Powell, Ben
    Zhang, Chao
    Ma, Yan
    Narahara, Maiko
    Sumi, Hiroyuki
    Bollag, Gideon
    Levis, Mark J.
    BLOOD, 2019, 134
  • [27] A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia
    Lee, Lauren
    Hizukuri, Yoshiyuki
    Severson, Paul
    Powell, Benjamin
    Zhang, Chao
    Ma, Yan
    Narahara, Maiko
    Sumi, Hiroyuki
    Hernandez, Daniela
    Rajkhowa, Trivikram
    Bollag, Gideon
    Levis, Mark
    HAEMATOLOGICA, 2021, 106 (04) : 1022 - 1033
  • [28] Effective Combination of CPX-351 with FLT3 Inhibitors in AML Blasts Harboring the FLT3-ITD Mutation
    Edwards, David K.
    Javidi-Sharifi, Nathalie
    Rofelty, Angela
    Rosenfeld, Claire
    Roth-Carter, Riley
    Tardi, Paul
    Mayer, Lawrence
    Tyner, Jeffrey W.
    BLOOD, 2016, 128 (22)
  • [29] Old Meets New: Hydroxyurea Synergistically Enhances the Antileukemic Activity of Gilteritinibagainst FLT3-ITD AML
    Eid, Nibal
    Zhao, Jianlei
    Thibodeau, Jenna
    Edwards, Holly
    Polin, Lisa
    Kushner, Juiwanna
    Dzinic, Sijana H.
    White, Kathryn H.
    Buck, Steven
    Taub, Jeffrey W.
    Ge, Yubin
    BLOOD, 2024, 144 : 5805 - 5806
  • [30] Developing dual FLT3/MNK inhibitors to overcome sorafenib resistance in FLT3-ITD AML cells
    Zhao, Linxiang
    Zuo, Shuwei
    Xing, Kun
    Yue, Xiaoshuang
    Zhang, Huimin
    Zhang, Jingyi
    Waxman, Samuel
    Jing, Yongkui
    CANCER RESEARCH, 2024, 84 (06)
12345